SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $504,000 | -16.0% | 46,629 | -14.5% | 0.08% | +14.3% |
Q1 2016 | $600,000 | +25.0% | 54,537 | +11.5% | 0.07% | +29.6% |
Q2 2015 | $480,000 | -8.0% | 48,900 | -17.1% | 0.05% | +1.9% |
Q1 2015 | $522,000 | +255.1% | 58,957 | +250.9% | 0.05% | +103.8% |
Q4 2014 | $147,000 | – | 16,800 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |